The survival time of lymphoma metastasis to lung varies from person to person, generally about three months, depending on different age, physical condition and patients’ own conditions. In good economic condition, the survival time can be extended by timely application of targeted therapeutic drugs, gene therapy, and also by psychotherapy to reduce anxiety and depression, and by radiotherapy and chemotherapy to regulate the treatment. When lymphoma metastasizes to the lung, it means that the malignant tumor has reached the end stage, and its survival quality will be very poor, with severe pain, repeated infections and severe malnutrition. The patient’s body is very depleted, and many patients die because of malnutrition, while some patients die clinically because of severe intrapulmonary infections and decubitus ulcers.